Development of peripheral neuropathy and its association with survival during treatment with nab-paclitaxel plus gemcitabine for patients with metastatic adenocarcinoma of the pancreas: A subset analysis from a randomised phase III trial (MPACT)

Title
Development of peripheral neuropathy and its association with survival during treatment with nab-paclitaxel plus gemcitabine for patients with metastatic adenocarcinoma of the pancreas: A subset analysis from a randomised phase III trial (MPACT)
Authors
Keywords
Gemcitabine, nab, -Paclitaxel, Peripheral neuropathy, Pancreatic cancer
Journal
EUROPEAN JOURNAL OF CANCER
Volume 52, Issue -, Pages 85-91
Publisher
Elsevier BV
Online
2015-12-01
DOI
10.1016/j.ejca.2015.10.017

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More